Liontrust Investment Partners »

Recursion Pharmaceuticals shares owned by Liontrust Investment Partners

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Liontrust Investment Partners from 13F filings

Historical chart of Liontrust Investment Partners investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by Liontrust Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by Liontrust Investment Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $7.4M 990k 7.50
2024-06-30 $7.4M 990k 7.50
2024-03-31 $7.5M 750k 9.97
2023-09-30 $4.0M 520k 7.65

More positions owned by Liontrust Investment Partners

Microsoft Corp Msft Uw Equity (MSFT)
Visa Inc-class A Shares V Us Equity (V)
Cadence Design Sys Inc Cdns Us Equity (CDNS)
Thermo Fisher Scientific Inc Tmo Un Equity (TMO)
PTC Equity (PTC)
Iqvia Holdings Inc Iqv Us Equity (IQV)
Spotify Technology Sa Equity (SPOT)
Intuitive Surgical Inc Isrg Us Equity (ISRG)
Intuit Inc Intu Us Equity (INTU)
Alcon Equity
Veralto Corp Equity (VLTO)
Ecolab Inc Ecl Us Equity (ECL)
Verisign Inc Vrsn Us Equity (VRSN)
Agilent Technologies Inc A Us Equity (A)
American Tower Corp Amt Us Reit (AMT)

View all positions for Liontrust Investment Partners

Top funds holding Recursion Pharmaceuticals

ARK Investment Management
Baillie Gifford & Co
Vanguard Group
BlackRock
RA Capital Management
Mubadala Investment Co PJSC
State Street Corporation
Kinnevik AB
Nikko Asset Management Americas
Sumitomo Mitsui Trust Holdings
MIC Capital Management UK
FMR
Nvidia Corp
Data Collective IV GP
Geode Capital Management

View all funds holding Recursion Pharmaceuticals